In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Clinical characteristics and quality of life of patients with atrial fibrillation in the Colombian Heart Failure Registry - RECOLFACA

Session Poster Session 3

Speaker Juan Esteban Gomez

Event : Heart Failure 2019

  • Topic : heart failure
  • Sub-topic : Acute Heart Failure – Epidemiology, Prognosis, Outcome
  • Session type : Poster Session

Authors : JUAN Gomez-Mesa (Cali,CO), LUIS Echeverria (Floridablanca,CO), CLARA Saldarriaga (Medellin,CO)

JUAN Gomez-Mesa1 , LUIS Echeverria2 , CLARA Saldarriaga3 , 1Fundación Universitaria Valle del Lili - Cali - Colombia , 2Fundación Cardiovascular de Colombia - Floridablanca - Colombia , 3Clinica Cardio Vid - Medellin - Colombia ,

On behalf: RECOLFACA Investigators


Background: The prevalence of atrial fibrillation (AF) in patients with heart failure (HF) has been reported between 13% and 27%. The explanation for this coexistence has been the presence of common risk factors. The objective of this work is to compare demographic, clinic characteristics and quality of life (QoL) of patients with and without AF in a cohort of HF patients in Colombia.

Methods: RECOLFACA registry collected data prospectively from September 2016 to September 2018, including 2,099 patients from 60 institutions: 416 patients with AF and 1683 patients without AF. Demographic, clinical characteristics and QoL (EQ5D-3L instrument) were evaluated using Chi-Square, Student T and Mann Whitney Tests. Multivariable analysis was performed through logistic regression. Significance difference was defined as 0.05.

Results: The prevalence of AF was 20%. Mean age of patients with AF was 73.87 (10.42), older than patients without AF (p<0.0001). There was no difference in sex. Multivariable analysis demonstrated that AF was associated with higher arterial hypertension (p<0.010), higher depression (p=0.015), lower type 2 diabetes mellitus (p=0.0001) and more proportion of patients in ACC/AHA stage A (p=0.022). On the follow up, AF was associated with higher non-controlled arterial hypertension (p=0.006), higher progression of the disease (p=0.001) and higher arrhythmias (p>0.0001) as factor of decompensated of HF. Mean score of QoL was 74.72 (21.49) on patients with AF and 80.04 (20.92) on patients without AF, where the domains of mobility, self-care, usual activities, and pain/discomfort showed statistically significant difference.

Conclusions: Atrial fibrillation is a common comorbidity in our HF population. AF is related to more uncontrolled arterial hypertension, depression and elderly age. QoL is lower in AF group. Arrhythmias are more frequent as a factor of HF decompensation.

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are